AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10874258
Drug: Enoxaparin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (1 mg/kg) alone
Trial: 1587753
Drug: Stereotactic interstitial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic interstitial brachytherapy with iodine-125 implants
Trial: 30255418
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg BID
Trial: 20721488
Drug: 80 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/kg body weight of oral praziquantel divided in two equal doses with 1 h interval (Group 1)
Trial: 20721488
Drug: 50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/kg body weight of oral praziquantel (Group 2)
Trial: 12534505
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type B (3 injections of 250 U each, total 750 U)
Trial: 8638792
Drug: Verapamil 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 0.1 mg/kg
Trial: 8638792
Drug: Verapamil 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 0.05 mg/kg
Trial: 8638792
Drug: Diltiazem 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 0.2 mg/kg
Trial: 8186137
Drug: Terbinafine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (250 mg/day)
Trial: 8186137
Drug: Itraconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (100 mg/day)
Trial: 2526824
Drug: Acitretin 25
RxNorm normalized name: acitretin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin 25 mg/day
Trial: 22816881
Drug: Acitretin 35
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 35 mg/day
Trial: 2467488
Drug: Acitretin 45
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 45 mg/day
Trial: 2467488
Drug: Acitretin 55
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 55 mg/day
Trial: 2467488
Drug: Acitretin (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (after discontinuation)
Trial: 2467488
Drug: Acitretin (dosages
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (dosages 45 or 55 mg/day)
Trial: 19623197
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg daily)
Trial: 17244103
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patch (Duragesic, 25 microg/h)
Trial: 15492435
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied three times a week for 12 weeks
Trial: 9561935
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment (i.t.)
Trial: 10163331
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with antisecretory or cytoprotective drugs
Trial: 31802120
Drug: Intradermal (ID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal (ID) 3-dose schedule
Trial: 31802120
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) 2-dose schedule
Trial: 31802120
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) 3-dose schedule
Trial: 28333997
Drug: Repetitive practice
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repetitive practice (same exergame - ski slalom, twice weekly for 20 minutes over 5 weeks)
Trial: 18923786
Drug: Sensory-motor-oral stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensory-motor-oral stimulation and non-nutritive sucking
Trial: 16361296
Drug: Ganirelix (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganirelix (0.25 mg/day)
Trial: 2401028
Drug: Calan tablet
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calan tablet 5 mg, administered 3 times a day for 6 weeks.
Trial: 26992090
Drug: Metformin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin with supplemental insulin
Trial: 26992090
Drug: Metformin (Hr1-GTT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (Hr1-GTT >212 mg/dL)
Trial: 26992090
Drug: Metformin (Wk1-mFG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (Wk1-mFG >95 mg/dL)
Trial: 17420344
Drug: Copeptin above
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copeptin above the median (approximately 7 pmol/L) in patients with NTproBNP above the median (approximately 900 pmol/L)
Trial: 16390748
Drug: LHRH‐A therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRH‐A therapy
Trial: 12045509
Drug: Combined joint
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined joint manipulation and myofascial therapy
Trial: 10825037
Drug: HA-1A (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-1A (6 mg/kg of body weight iv; maximum, 100 mg)
Trial: 8829888
Drug: Oral ebastine
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ebastine
Trial: 2704543
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A ointment (all-trans retinoic acid)
Trial: 7009819
Drug: Rifampin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (10 mg/kg/dose, 600 mg/dose maximum, twice daily for two days)
Trial: 28536029
Drug: CIGB-247 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIGB-247 vaccine with adjuvant VSSP, specific anti-VEGF IgG titer diminished but remained above pre-vaccination levels, gradual shift in anti-VEGF IgG response from IgG1 to IgG4, maintained antibodies able to interfere with VEGF/Receptor interaction, production of IFNγ secretion in CD8+ cells.
Trial: 10668836
Drug: Amlodipine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine therapy
Trial: 22885164
Drug: Rituximab chemotherapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab chemotherapy induction and 2-year rituximab maintenance
Trial: 22885164
Drug: Rituximab chemotherapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab chemotherapy induction and maintenance
Trial: 18335394
Drug: Pharmacological intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmacological intervention with metformin or acarbose
Trial: 16277712
Drug: Subcutaneous rHuEPO
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous rHuEPO 40,000 units once per week (group A)
Trial: 16277712
Drug: Subcutaneous rHuEPO
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous rHuEPO 40,000 units three times per week (group B)
Trial: 16277712
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intravenous iron saccharate alone)
Trial: 7917794
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg) alone
Trial: 2288835
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg) after pretreatment with oral co-trimoxazole
Trial: 6352641
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of azlocillin and tobramycin
Trial: 22516668
Drug: Untried atypical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untried atypical antipsychotic (phase 2E)
Trial: 19408475
Drug: Mineralized collagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mineralized collagen bone substitute (MCBS) combined with recombinant human platelet-derived growth factor-BB (0.3 mg/mL)
Trial: 17761236
Drug: Nutrition computer
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition computer modules (oral rehydration therapy, calcium, and vitamins) on compact disc for study over 6 weeks
Trial: 2502417
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg simvastatin
Trial: 7848228
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg prostaglandin F2 alpha (PGF2 alpha) applied intracervically
Trial: 7848228
Drug: Standard oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard oxytocin intravenous infusion
Trial: 6203496
Drug: Electroconvulsive treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive treatments (ECTs)
Trial: 21177797
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg soy hypocotyl isoflavones
Trial: 16187969
Drug: BMT (bismuth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMT (bismuth biskalcitrate, metronidazole, tetracycline) administered with food
Trial: 12792359
Drug: Group drug
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group drug counseling (GDC)
Trial: 10669989
Drug: Re-treatment with
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Re-treatment with triple regimen
Trial: 10669989
Drug: Re-treatment with
RxNorm normalized name: Re-Covr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Re-treatment with dual therapy
Trial: 30316489
Drug: Audio-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Audio-based cognitive behavioral therapy (ACBT)
Trial: 25026919
Drug: Black chokeberry
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black chokeberry juice (89 mL per resident daily for 3 months in group B)
Trial: 22261573
Drug: HiCarb/LoProt diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HiCarb/LoProt diet (glucose 10 mg · kg(‐1) · min(‐1)/protein 0.7 g · kg(‐1) · d(‐1))
Trial: 22261573
Drug: NormCarb/LoProt diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NormCarb/LoProt diet (glucose 7.5 mg · kg(‐1) · min(‐1)/protein 0.3 g · kg(‐1) · d(‐1))
Trial: 20039931
Drug: High-dose tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tirofiban with enoxaparin
Trial: 20039931
Drug: High-dose tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tirofiban with unfractionated heparin (UFH)
Trial: 27648752
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy (CT) for SAD
Trial: 20395096
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg of vitamin C)
Trial: 18555812
Drug: 30 mcg
RxNorm normalized name: Avonex 30 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mcg ethinyl estradiol plus 3 mg drospirenone (Group A)
Trial: 12484508
Drug: CCB (amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCB (amlodipine 5 mg once daily)
Trial: 12484508
Drug: ACE‐I (temocapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE‐I (temocapril 2 mg once daily)
Trial: 12484508
Drug: ARB (candesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB (candesartan 4 mg once daily) added to CCB
Trial: 12484508
Drug: ARB (candesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB (candesartan 4 mg once daily) added to ACE‐I
Trial: 10717757
Drug: Amodiaquine 30
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amodiaquine 30 mg/kg
Trial: 17488902
Drug: Chloroquine 25
RxNorm normalized name: chloroquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 25 mg/kg
Trial: 7491391
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg of Methylphenidate (MPH)
Trial: 7491391
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg of Methylphenidate (MPH)
Trial: 2975095
Drug: Isradipine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (0.5 mg)
Trial: 1834462
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 ml solvent)
Trial: 28327696
Drug: 1.5 mm
RxNorm normalized name: blade lancet, safety 1.5 mm X 2 mm MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mm subcrestal implant placement
Trial: 28327696
Drug: 0.5 mm
RxNorm normalized name: OptiMARK, 0.5 mmol/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mm subcrestal implant placement
Trial: 28873376
Drug: 32 mg
RxNorm normalized name: caffeine 32 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 mg cathine
Trial: 28873376
Drug: 53.3 mg
RxNorm normalized name: phosphorus 53.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 53.3 mg cathine
Trial: 21153030
Drug: Intravenous L:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L: -arginine (10 g in 20 min)
Trial: 30076270
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day donepezil
Trial: 11139914
Drug: Steroid-eluting coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-eluting coronary venous leads
Trial: 26906129
Drug: Involvement in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involvement in treatment decision making
Trial: 8173149
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg qd
Trial: 15694088
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 microg)
Trial: 12153552
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg day-1
Trial: 9649261
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg finasteride daily for 9 months
Trial: 30355640
Drug: Daily digital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily digital air leak measurements
Trial: 21067018
Drug: Injection Spectinomycin
RxNorm normalized name: spectinomycin Injectable Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection Spectinomycin 2 gm
Trial: 14600930
Drug: Solid meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solid meal (100 g ground beef labelled with 25 MBq (99m)Tc sulphur colloid)
Trial: 14600930
Drug: Liquid meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid meal (150 ml 10% glucose drink labelled with 8 MBq (67)Ga citrate)
Trial: 9342984
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received only anesthetic drugs
Trial: 31736357
Drug: Udenafil 87.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Udenafil 87.5 mg twice daily
Trial: 22016911
Drug: Oral‐B Indicator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral‐B Indicator 35 (compact head)
Trial: 27283367
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) plus narrow-band UVB phototherapy for 8 weeks
Trial: 31856900
Drug: mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mupirocin ointment
Trial: 20461001
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion (target concentrations: 4-9 ng/ml; infusion rates: 0.17-9 ng x ml x min)
Trial: 20461001
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion with low-dose propofol
Trial: 20461001
Drug: Simulation study
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulation study at varying remifentanil infusion speeds
Trial: 10822283
Drug: Extruded dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extruded dry beans (110 g/day)
Trial: 1623914
Drug: Ketoprofen (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (25 mg)
Trial: 6991534
Drug: Aspirin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (500 mg)
Trial: 3333162
Drug: Pentoxifylline (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (1200 mg/day per os, Trental 400 t.i.d.)
Trial: 25002731
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) 16 mg twice daily
Trial: 16358378
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UH)
Trial: 1835229
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) with an intensive schedule (0, 1 months for HBIg; 0, 1, 2, 6 months for vaccine)
Trial: 1835229
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) for males
Trial: 6188917
Drug: pindolol (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol (average 12 mg/day)
Trial: 11901445
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 3200 microg of budesonide
Trial: 9740606
Drug: Lisinopril (n=84)
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril (n=84)
Trial: 9740606
Drug: Lisinopril plus
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril plus hydrochlorothiazide (n=91)
Trial: 9740606
Drug: Lisinopril and
RxNorm normalized name: lisinopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril and Lisinopril plus hydrochlorothiazide
Trial: 2112166
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin ointment (Bactroban)
Trial: 7044804
Drug: Fenbufen (600-1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenbufen (600-1000 mg/day, b.i.d.)
Trial: 7044804
Drug: Indomethacin (750-125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (750-125 mg/day, b.i.d.)
Trial: 30705040
Drug: Intravitreal ziv-aflibercept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ziv-aflibercept (IVZ) 1.25 mg/0.05 mL administered 1-10 days before PPV
Trial: 30705040
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (IVB) 1.25 mg/0.05 mL administered 1-10 days before PPV
Trial: 29246725
Drug: Curcumin (Theracurmin®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (Theracurmin® 90 mg twice daily)
Trial: 26707868
Drug: OP (FemSeven
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OP (FemSeven 100μg/24h patches)
Trial: 22715739
Drug: Dahuang Zhechong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dahuang Zhechong Wan combined with adefovir dipivoxil (10 mg of adefovir dipivoxil once a day, 1 Wan each time, combined with Dahuang Zhechong Wan, 3 times a day, 1 Wan each time)
Trial: 6332895
Drug: Soy isolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isolate formula supplemented with calcium (92 mg/kg/day), phosphorus (44 mg/kg/day), and vitamin D (500 IU/kg/day)
Trial: 21865946
Drug: Neoadjuvant chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemoradiation therapy (CRT)
Trial: 20569667
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of complementary and alternative medicine (CAM)
Trial: 10476746
Drug: Imipenem (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem (50 mg/(kg x d))
Trial: 10476746
Drug: Ceftazidime (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (120 mg/(kg x d))
Trial: 9004051
Drug: Fluvoxamine (50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (50-150 mg/day)
Trial: 8899132
Drug: Fluvoxamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (50 mg/day)
Trial: 31819319
Drug: GLP‐1 infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐1 infusion (1.5 pmol/kg/min)
Trial: 31819319
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mL of 0.9% saline)
Trial: 27839782
Drug: 0.5mg/kg ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5mg/kg ketamine infusion
Trial: 16828804
Drug: Rasagiline 1
RxNorm normalized name: rasagiline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 1 mg
Trial: 21482191
Drug: Rasagiline 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 2 mg